Polymorphism of metabolisation and clinical implications

Profile of Isoniazid Acetylation Phenotype in Rwandan healthy subjects and Tuberculosis patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201406000609270

Enrollment

200

Registered

2013-08-07

Start date

2012-01-02

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Interventions

Healthy volunteers

TB Patients

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy individual Volunteer Tuberculosis patient Naive on TB and HIV drugs Inpatient

Exclusion criteria

Exclusion criteria: No pregnancy No any medication 72 hours before

Design outcomes

Primary

Measure	Time frame
Acetylator class: slow, intermediate, fast;Impact of Phenotype on clinical outcomes	—

Countries

Rwanda

Contacts

Public ContactAndre Musemakweri

Dr/Butare university teaching hospital

amusemakweri@nur.ac.rw+250788592150

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026